Research topics - Pharmacologic degradation of targets that prevent prostate cancer progression under hormonal therapy
The androgen receptor represents a key therapeutic target in prostate cancer exploited by hormonal therapies. Upon hormonal therapy, we discover a crucial role for previously discovered co-activators in supporting the survival of residual cell clusters primed for tumor relapse.
